Search Within

Alexander Edward Drilon

  1. "Biostatistics Service"
Formats
  1. Journal Article (36)
  2. Meeting Abstract (24)
  3. Correspondence (1)
  4. Research Letter (1)
Groups
  1. Biostatistics Service (62)
  2. Department of Medicine (62)
  3. Epidemiology and Biostatistics (62)
  4. Solid Tumor Oncology Division (62)
  5. Thoracic Oncology (62)
  6. GSK Faculty (42)

More Groups

People
  1. Bob Li (33)
  2. Charles Rudin (31)
  3. Maria Arcila (27)
  4. Mark Kris (26)
  5. Michael Offin (23)
  6. Gregory Riely (21)

More People

Years
  1. 2025 (2)
  2. 2024 (5)
  3. 2023 (5)
  4. 2022 (8)
  5. 2021 (7)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (17)
  2. Clinical Cancer Research (8)
  3. Journal of Thoracic Oncology (7)
  4. Annals of Oncology (3)
  5. Cancer (3)
  6. International Journal of Radiation Oncology, Biology, Physics (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (20)
  2. Elsevier Inc. (13)
  3. American Association for Cancer Research (10)
  4. Oxford University Press (5)
  5. Elsevier Ireland Ltd. (3)
  6. Wiley Blackwell (3)

More Publishers

Results (62)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RET-rearranged lung cancers: Immunophenotype and response to immunotherapy
    Meeting Abstract

    Sabari, J. K.; Offin, M. D.; Wu, S. L.; Ni, A.; Halpenny, D.; Montecalvo, J.; Liu, D.; Pak, T. K.; Arbour, K. C.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Circulating tumor DNA in advanced lung cancers: A prospective evaluation of matched therapy and shedding detection
    Meeting Abstract

    Offin, M. D.; Stephens, D.; Sabari, J. K.; Makhnin, A.; Myers, M.; Ni, A.; Pavlakis, N.; Clarke, S. J.; Tandon, N.; Datta, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression, tumor mutation burden and response to immune checkpoint blockade in patients with HER2-mutant lung cancers
    Meeting Abstract

    Lai, W. C. V.; Feldman, D. L.; Buonocore, D. J.; Brzostowski, E. B.; Rizvi, H.; Plodkowski, A. J.; Ni, A.; Sabari, J. K.; Offin, M. D.; Kris, M. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of brain metastases and outcomes in patients with HER2-, KRAS-, and EGFR-mutant lung cancers
    Meeting Abstract

    Kris, M. G.; Offin, M. D.; Feldman, D. L.; Ni, A.; Lai, W. C. V.; Arbour, K. C.; Daras, M.; Pentsova, E.; DeAngelis, L. M.; Beal, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Detecting HER2 alterations by next generation sequencing (NGS) in patients with advanced NSCLC from the United States and China
    Meeting Abstract

    Xu, C.; Zhang, Y.; Liu, D.; Shen, R.; Razavi, P.; Liu, S.; Sun, H.; Offin, M.; Drilon, A.; Rudin, C.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • MET exon 14-altered lung cancers: Central nervous system (CNS) metastases and patterns of CNS progression on MET inhibition
    Meeting Abstract

    Offin, M.; Dienstag, J.; Wilkins, O.; Sabari, J.; Ni, A.; Feldman, D.; Van Voorthuysen, M.; Suzawa, K.; Yu, H.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers
    Journal Article

    Sabari, J. K.; Leonardi, G. C.; Shu, C. A.; Umeton, R.; Montecalvo, J.; Ni, A.; Chen, R.; Dienstag, J.; Mrad, C.; Bergagnini, I.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine for patients with HER2-mutant lung cancers: Results from a phase II basket trial
    Journal Article

    Li, B. T.; Shen, R. L.; Buonocore, D.; Olah, Z. T.; Ni, A.; Ginsberg, M. S.; Ulaner, G. A.; Offin, M.; Feldman, D.; Hembrough, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of brain metastases and multikinase inhibitor outcomes in patients with RET–rearranged lung cancers
    Journal Article

    Drilon, A.; Lin, J. J.; Filleron, T.; Ni, A.; Milia, J.; Bergagnini, I.; Hatzoglou, V.; Velcheti, V.; Offin, M.; Li, B.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • CT features of HER2-mutant lung adenocarcinomas
    Journal Article

    Sawan, P.; Plodkowski, A. J.; Li, A. E.; Li, B. T.; Drilon, A.; Capanu, M.; Ginsberg, M. S.
    Clinical Imaging (2018)

    Fulltext@MSK | Save